Clinical Utility: AChR Blocking autoantibodies are directed against the neurotransmitter-binding sites and may be the only AChR autoantibody in approximately 1% of Myasthenia gravis patients.
Serum (1 mL)
Ambient 14 Days
Refrigerated 14 Days
Frozen 30 Days
Enter your information below